Somnoware Healthcare Methods is partnering with Cerebra Medical to combine Cerebra’s autoscoring know-how, MY Autoscoring, into the Somnoware platform.
This partnership will allow automated sleep research scoring instantly throughout the Somnoware platform. MY Autoscoring enhances the accuracy, consistency, and effectivity of human scorers, scoring a whole polysomnogram (PSG) in lower than 5 minutes. The outcomes of the automated scoring are then reviewed and edited by a sleep specialist who will use the knowledge to diagnose and deal with the affected person if a sleep problem is detected.
“Somnoware and Cerebra are a pure match,” mentioned Subath Kamalasan, Somnoware CEO. “Somnoware’s platform automates diagnostic testing workflows and affected person remedy interventions. With MY Autoscoring, clinicians will now be capable of automate sleep research scoring throughout the Somnoware platform. The mixed time-savings for clinicians utilizing the built-in platforms is gigantic and can scale back prices, lower testing backlogs, and unencumber time for affected person care.”
Immediately MY Autoscoring exists as a function within the Cerebra Sleep System and is known as after inventor and Cerebra Scientific Founder, Magdy Younes, MD, PhD, FRCPC, who spent greater than a decade growing the know-how. In two revealed research throughout a broad vary of sleep sorts, MY Autoscoring carried out in addition to professional handbook scoring in a side-by-side comparability for all PSG variables.1,2
Somnoware’s partnership with Cerebra seamlessly integrates the 2 platforms. Somnoware orchestrates information circulate between disparate medical gadgets, unifies datasets inside a single platform, and delivers high-impact analytics. The answer permits screening, sooner analysis, proactive intervention, and automatic affected person engagement, leading to improved therapy outcomes for sufferers with respiratory illnesses, together with sleep issues and COPD.
“Somnoware is the main integration innovator in sleep drugs,” mentioned Patrick Crampton, Cerebra President & COO. “With the addition of MY Autoscoring, the sleep drugs neighborhood has a platform that not solely integrates their testing gadgets and EHR, but in addition sleep research autoscoring. We stay up for broadening the scope of integration with Cerebra.”
MY Autoscoring consists of Odds Ratio Product (ORP), a Cerebra patented algorithm that goes past typical scoring by micro analyzing the EEG sign, figuring out a affected person’s sleep depth in every sleep stage. This info is used to higher perceive a affected person’s sleep high quality and assist within the analysis of sleep issues reminiscent of sleep apnea.
ORP identifies:
- Full wakefulness vs. drowsiness inside stage Wake, serving to determine the mechanism of extreme wake time.
- Stage of sleep depth in stage N2 that may determine the explanations for sleep signs when the visually derived hypnogram is regular utilizing typical metrics.
- Very deep sleep even when delta waves don’t meet standards for stage N3.
“We’re excited to announce our new strategic partnership with Cerebra Medical. This partnership is a game-changer for the sleep business as it should enable Somnoware to supply cutting-edge know-how that gives automated sleep research scoring to our purchasers,” mentioned Kamalasan. “With this new partnership, we can assist our clients enhance sleep research scoring effectivity. We’re wanting ahead to the constructive impression this partnership may have on the sleep drugs neighborhood and the sufferers they serve.”
References
1. Malhotra A, Younes M, Kuna ST, Benca R, Kushida CA, Walsh J, Hanlon, A, Staley B, Pack AI, Pien GW. Efficiency of an automatic polysomnography scoring system versus computer-assisted handbook scoring. Sleep. 2013;36(4): 573-582.
2. Younes M, Thompson W, Leslie C, Egan T, Giannouli E. Utility of technologist modifying of polysomnography scoring carried out by a validated automated system. Ann Am Thorac. 2015;12(8),1206-1218.
